» Articles » PMID: 37172950

Induction of Bleb Structures in Lipid Nanoparticle Formulations of MRNA Leads to Improved Transfection Potency

Overview
Journal Adv Mater
Date 2023 May 12
PMID 37172950
Authors
Affiliations
Soon will be listed here.
Abstract

The transfection potency of lipid nanoparticle (LNP) mRNA systems is critically dependent on the ionizable cationic lipid component. LNP mRNA systems composed of optimized ionizable lipids often display distinctive mRNA-rich "bleb" structures. Here, it is shown that such structures can also be induced for LNPs containing nominally less active ionizable lipids by formulating them in the presence of high concentrations of pH 4 buffers such as sodium citrate, leading to improved transfection potencies both in vitro and in vivo. Induction of bleb structure and improved potency is dependent on the type of pH 4 buffer employed, with LNP mRNA systems prepared using 300 mm sodium citrate buffer displaying maximum transfection. The improved transfection potencies of LNP mRNA systems displaying bleb structure can be attributed, at least in part, to enhanced integrity of the encapsulated mRNA. It is concluded that enhanced transfection can be achieved by optimizing formulation parameters to improve mRNA stability and that optimization of ionizable lipids to achieve enhanced potency may well lead to improvements in mRNA integrity through formation of the bleb structure rather than enhanced intracellular delivery.

Citing Articles

Emerging Gene Therapy Based on Nanocarriers: A Promising Therapeutic Alternative for Cardiovascular Diseases and a Novel Strategy in Valvular Heart Disease.

Yang H, Li J, Song C, Li H, Luo Q, Chen M Int J Mol Sci. 2025; 26(4).

PMID: 40004206 PMC: 11855571. DOI: 10.3390/ijms26041743.


Exploring the Effects of Incorporating Different Bioactive Phospholipids into Messenger Ribonucleic Acid Lipid Nanoparticle (mRNA LNP) Formulations.

Chen S, Wang S, Liao S, Blakney A ACS Bio Med Chem Au. 2025; 5(1):154-165.

PMID: 39990935 PMC: 11843334. DOI: 10.1021/acsbiomedchemau.4c00085.


Computational Methods for Modeling Lipid-Mediated Active Pharmaceutical Ingredient Delivery.

Paloncyova M, Valerio M, Dos Santos R, Kuhrova P, Srejber M, cechova P Mol Pharm. 2025; 22(3):1110-1141.

PMID: 39879096 PMC: 11881150. DOI: 10.1021/acs.molpharmaceut.4c00744.


Delivery of FGF18 using mRNA-LNP protects the cartilage against degeneration via alleviating chondrocyte senescence.

Kong K, Li B, Chang Y, Zhao C, Qiao H, Jin M J Nanobiotechnology. 2025; 23(1):34.

PMID: 39844298 PMC: 11753171. DOI: 10.1186/s12951-025-03103-9.


A novel micelleplex for tumour-targeted delivery of CRISPR-Cas9 against KRAS-mutated lung cancer.

Chen S, Triki M, Pinto Carneiro S, Merkel O Nanoscale. 2025; 17(11):6604-6619.

PMID: 39838780 PMC: 11751667. DOI: 10.1039/d4nr03471f.